Source: International Congress 2019 – Biomarkers and beyond in idiopathic interstitial pneumonia
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
K. Moor (Rotterdam, Netherlands), L. Visser (Rotterdam, Netherlands), J. Aerts (Rotterdam, Netherlands), V. Cottin (Lyon, France), M. Wijsenbeek (Rotterdam, Netherlands). Diurnal variation in forced vital capacity in patients with fibrotic interstitial lung disease using home spirometry: the DIVA study. 2246

Member's Comments

No comment yet.

Related content which might interest you: The ratio of inspiratory ΣRrs to expiratory ΣRrs measured by forced oscillation technique correlates with the parameters reflecting narrowing of small airway measured by spirometry in patients with mild to moderate COPD Source: Annual Congress 2013 –New issues in lung function testing Year: 2013 Spirometric evaluation of idiopathic pulmonary fibrosis (IPF): forced or slow vital capacity? Source: International Congress 2019 – Biomarkers of idiopathic interstitial pneumonia Year: 2019 Usefulness of post bronchodilator FVC in the evaluation and spirometric evolution of COPD patients Source: Annual Congress 2013 –Monitoring lung function in airway diseases Year: 2013 FEV6 or FVC to detect airway obstruction in the community setting? Source: Annual Congress 2007 - PG17 - Lung function measurement in the community Year: 2007 Positive expiratory pressure therapy improves inspiratory capacity and physical activity in patients with chronic obstructive pulmonary disease Source: Annual Congress 2013 –The best posters in exercise testing and physical inactivity Year: 2013 Prediction of air trapping or pulmonary hyperinflation by forced spirometry in COPD patients: results from COSYCONET Source: ERJ Open Res, 6 (3) 00092-2020; 10.1183/23120541.00092-2020 Year: 2020 Expiratory slope variations induce physiological changes in stroke volume during non invasive ventilation in hyperinflated COPD patients Source: International Congress 2018 – New insights in the management of chronic respiratory failure Year: 2018 The role of concomitant respiratory diseases on the rate of decline in FEV1 among adult asthmatics Source: Eur Respir J 2003; 21: 95-10 Year: 2003 Inspiratory capacity-to-total lung capacity ratio is related to expiratory flow limitation in patients with chronic obstructive pulmonary disease Source: Annual Congress 2007 - Lung function I Year: 2007 Changes in lung function in patients with acute COPD exacerbations: spirometry vs. forced oscillations Source: Eur Respir J 2001; 18: Suppl. 33, 149s Year: 2001 Can we use pre-bronchodilator spirometry to define post-bronchodilator airflow obstruction? Source: International Congress 2015 – Epidemiology of respiratory disease Year: 2015 Spirometry in old age: feasibility and interpretation Source: Eur Respir Mon; 2009: 43: 25–34 Year: 2009 Why should we perform lung function tests? Source: Annual Congress 2007 - PG17 - Lung function measurement in the community Year: 2007 Ventilation heterogeneity in COPD and healthy smokers relates to diffusion capacity, resistance and reactance Source: International Congress 2015 – Monitoring airway diseases with lung function tests Year: 2015 Exercise limitation in patients with interstitial lung disease independent from diffusion capacity (DLCO) Source: Annual Congress 2008 - Exercise: system responses Year: 2008 Does dynamic hyperinflation contribute to dyspnoea during exercise in patients with COPD? Source: Eur Respir J 2012; 40: 322-329 Year: 2012 Analysis of breathing acoustic parameters in patients with COPD, interstitial lung diseases and normal subjects Source: Annual Congress 2006 - Assessing the lungs in obstruction: technological advances in lung function testing Year: 2006 Forced inspiratory volume in one second (FIV1) in the assessment of reversibility of airway obstruction in patients with chronic obstructive pulmonary disease (COPD) and in relation to the severity Source: Eur Respir J 2002; 20: Suppl. 38, 300s Year: 2002 Forced vital capacity (FVC) decline in idiopathic pulmonary fibrosis (IPF) – modelling the myth Source: International Congress 2019 – The world of idiopathic pulmonary fibrosis Year: 2019